Highlights from Day 2 of ESMO Asia 2024

ESMO Asia is an annual congress focused on multidisciplinary oncology in the Asian region. ESMO Asia 2024 is being held from 6-8 December, at Singapore.

It provides a platform for participants to share and discuss the latest research findings, clinical trials, and treatment strategies in the field.The event brings together oncologists, researchers, healthcare professionals, and industry representatives from Asia and around the world.

ESMO Asia 2024 features scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer. Its educational sessions provide in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.

Healthcare Professionals and Organizations shared about this Conference on Social Media:

Tom Powles:

“Enfortumab Vedotin and Pembro in the Asian subgroup ESMO Asia24 (n=170). More UTUCs. CR 39%, PFS and OS HRs ~0.35 with CIs crossing ITT population showing at least equivalent activity. Some toxicity such as rash and hyperglycaemia prominent experience and training is important.”

Alejandro Berlin: 

“5 remarkable things:

– Melvin Chua – superb mentor and clinician-scientist
– Boon – superb trainee
– Genomic Classifier Decipher by Veracyte
– Best poster at ESMO Asia24
– Focal therapy for prostate cancer 

Just one that causes more harm than good – take your guess.”

Liz Connolly:

“Congratulations to Dr Hing – Best Poster award winner at ESMO Asia24 in the ESMO YO Clinical Cases track

So many excellent cases and presenters. Difficult to choose the only one!”

Cathy Eng:

“Best travel companion to ESMO Asia24! Michael Gibson before and after our 22+ hour flight! Still smiling.”

Sanjay Popat:

“Discussing the optimal sample size needed to taste the difference between and high-end and standard durian. Should we be blinded? Any views on the design?”

Lorenza Rimassa:

“Personalizing GI oncology session at ESMOAsia24. Angela Lamarca discusses actionable targets e clinical challenges in BTC – biliary tract cancer.”

Viji Venkatesh:

“‘We know the faces of cancer. It’s time to hear the voices’.

WHO presentation at the ESMO Patient Engagement Summit at the ESMO Asia24 in Singapore. And we at The Max Foundation, Friends Of Max amplify those very voices.”

Luis Posado: 

“Happy to have presented at ESMO ASIA24 the work we conducted at the Medical Oncology Department of Salamanca on the impact of palliative care in patients with advanced lung cancer. Also delighted to have included a mention of my city (Zamora) in the acknowledgments slide!”

Georgina Long:

“It is an incredible honour to be scientific co-chair for ESMOAsia24 congress program with Prof Hanneke van Laarhoven Amsterdam UMC. Largest ESMO Asia congress from ESMO yet!

Top 10 cancers in Asia are lung, liver, stomach, breast, colorectal, oesophageal, nasopharyngeal, cervical, head/neck, and prostate, but the region so diverse, with different cancer risk factors, different populations and different health care systems. So much to learn from one another.

Informative discussions at highlight session on latest trials of drug therapies – covered EGFR mutant lung cancer plus bladder, anal and hepatocellular cancer. Presidential dinner and networking/collaborations to strive for better cancer outcomes for our patients.”

Prashant Kumar:

“An outstanding presentation by my good friend Aju Mathew on magnitude of clinical benefit in high-income Countries (HIC) and LMC, and Access to Drugs.”

Viji Venkatesh:

“India – Wake Up ! Air Pollution related cancers is a reality .
ESMO Patient Engagement Summit.”

Omali Pitiyarachchi:

“Prof Zarnie Lwin – updates in the treatment of gliomas; 2021 classification change, vorasidenib and dx in resource limited settings.”

Apoorv Suresh: 

“It was a pleasure for us to meet Michael Jefford who gave an excellent talk on ‘Improving the model of care for cancer survivors’ at ESMO Asia24.

With my friend and colleague Jiefang Huang.”

Sewanti Limaye: 

“Privileged to have presented on Genomics in Breast and Ovarian Cancers at ESMOAsia24; amongst great leaders like Dr. Daniel Chan, Herbert Loong, Dejan Juric, Dr YapYoonSim, Dr AyaElHelali.”

Dhanashri Kudal:

“Had great discussion with ESMO designated centres palliative care physicians and oncologists.”

Udai Banerji:

“Great session on advances in drug development at ESMO Asia24 at Singapore. Discussing use of AI including machine learning, CNN, LLMs that we use without actually knowing it!”

Michael Jefford:

“Great survivorship session at ESMOAsia24 – thanks for having us, thanks for all who came along!”

Lorenza Rimassa:

“Have we seen everything from checkpoint inhibitors? Amazing session at ESMO Asia 24 in Singapore chaired by Toh Han Chong and Elena Garralda.”

Omali Pitiyarachchi: 

“What a selfie! Australia and New Zealand representation in Singapore.”

Melissa Eastgate:

“The Trans Tasman table at ESMO Asia24 Presidential Dinner.”

Hongcheng Zhu:

“Great last ESMOYOC session of ESMO Asia24 with the Vesalius talk about Opportunities and challenges in global oncology for Young Oncologists from Asia-Pacific, fantastic discussion with Herbert Loong, Sanjay Popat, Joycelyn Lee!!!”

Highlights from Day 1 of ESMO Asia 2024